Autoimmune regulator and self-tolerance - molecular and clinical aspects

Immunological Reviews

Volumn 271, Issue 1, 2016, Pages 127-140

  Abramson, Jakub ^a   Husebye, Eystein S ^b,c  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b UNIVERSITY OF BERGEN   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Autoantibodies; Autoimmune polyendocrine syndrome type 1; Autoimmune regulator; Autoimmunity; Medullary thymic epithelial cell; T regulatory cell

Indexed keywords

AUTOIMMUNE REGULATOR PROTEIN; DNA; PROTEIN KINASE; RAG1 PROTEIN; RAG2 PROTEIN; SIRTUIN 1; TRANSCRIPTION FACTOR FOXP3; AUTOANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; AUTOIMMUNITY; GENE EXPRESSION; GENE MUTATION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LOSS OF FUNCTION MUTATION; MOLECULAR BIOLOGY; MYASTHENIA GRAVIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PURIFYING SELECTION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; THYMOMA; THYMUS; ANIMAL; ANTIGEN MEDIATED CLONAL SELECTION; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; POLYENDOCRINOPATHY;

ANIMALS; AUTOANTIGENS; AUTOIMMUNITY; CENTRAL TOLERANCE; CLONAL SELECTION, ANTIGEN-MEDIATED; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; POLYENDOCRINOPATHIES, AUTOIMMUNE; T-LYMPHOCYTES, REGULATORY; TRANSCRIPTION FACTORS;

EID: 84963569487     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/imr.12419     Document Type: Article

References (110)

1. Cooper GS, Bynum ML, Somers EC. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun 2009;33:197-207.
2. Marson A, Housley WJ, Hafler DA. Genetic basis of autoimmunity. J Clin Invest 2015;125:2234-2241.
3. Husebye ES, Perheentupa J, Rautemaa R, Kampe O. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. J Intern Med 2009;265:514-529.
4. Kisand K, et al. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med 2010;207:299-308.
5. Puel A, et al. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med 2010;207:291-297.
6. Oftedal BE, et al. Dominant mutations in the autoimmune regulator AIRE are associated with common organ-specific autoimmune diseases. Immunity 2015;42:1185-1196.
7. An autoimmune disease. APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. The Finnish-German APECED Consortium. Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy. Nat Genet 1997;17:399-403.
8. Nagamine K, et al. Positional cloning of the APECED gene. Nat Genet 1997;17:393-398.
9. Anderson MS, et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 2002;298:1395-1401.
10. Sansom SN, et al. Population and single-cell genomics reveal the Aire dependency, relief from Polycomb silencing, and distribution of self-antigen expression in thymic epithelia. Genome Res 2014;24:1918-1931.
11. Meredith M, Zemmour D, Mathis D, Benoist C. Aire controls gene expression in the thymic epithelium with ordered stochasticity. Nat Immunol 2015;16:942-949.
12. + regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells. Nat Immunol 2007;8:351-358.
13. Yang S, Fujikado N, Kolodin D, Benoist C, Mathis D. Immune tolerance. Regulatory T cells generated early in life play a distinct role in maintaining self-tolerance. Science 2015;348:589-594.
14. Peterson P, Org T, Rebane A. Transcriptional regulation by AIRE: molecular mechanisms of central tolerance. Nat Rev Immunol 2008;8:948-957.
15. Mathis D, Benoist C. Aire. Annu Rev Immunol 2009;27:287-312.
16. Abramson J, Goldfarb Y. AIRE: from promiscuous molecular partnerships to promiscuous gene expression. Eur J Immunol 2015. doi:10.1002/eji.201545792. [Epub ahead of print].
17. Cheng MH, et al. Acquired autoimmune polyglandular syndrome, thymoma, and an AIRE defect. N Engl J Med 2010;362:764-766.
18. Wolff AS, et al. Clinical and serologic parallels to APS-I in patients with thymomas and autoantigen transcripts in their tumors. J Immunol 2014;193:3880-3890.
19. Walter JE, et al. Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency. J Clin Invest 2015;125:4135-4148.
20. Cavadini P, et al. AIRE deficiency in thymus of 2 patients with Omenn syndrome. J Clin Invest 2005;115:728-732.
21. Perniola R, Musco G. The biophysical and biochemical properties of the autoimmune regulator (AIRE) protein. Biochim Biophys Acta 2014;1842:326-337.
22. Ferguson BJ, et al. AIRE's CARD revealed, a new structure for central tolerance provokes transcriptional plasticity. J Biol Chem 2008;283:1723-1731.
23. Kao WP, Yang CY, Su TW, Wang YT, Lo YC, Lin SC. The versatile roles of CARDs in regulating apoptosis, inflammation, and NF-kappaB signaling. Apoptosis 2015;20:174-195.
24. Pitkanen J, et al. The autoimmune regulator protein has transcriptional transactivating properties and interacts with the common coactivator CREB-binding protein. J Biol Chem 2000;275:16802-16809.
25. Kumar PG, et al. The autoimmune regulator (AIRE) is a DNA-binding protein. J Biol Chem 2001;276:41357-41364.
26. Waterfield M, et al. The transcriptional regulator Aire coopts the repressive ATF7ip-MBD1 complex for the induction of immunotolerance. Nat Immunol 2014;15:258-265.
27. Cetani F, et al. A novel mutation of the autoimmune regulator gene in an Italian kindred with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, acting in a dominant fashion and strongly cosegregating with hypothyroid autoimmune thyroiditis. J Clin Endocrinol Metab 2001;86:4747-4752.
28. Su MA, et al. Mechanisms of an autoimmunity syndrome in mice caused by a dominant mutation in Aire. J Clin Invest 2008;118:1712-1726.
29. Bottomley MJ, Collard MW, Huggenvik JI, Liu Z, Gibson TJ, Sattler M. The SAND domain structure defines a novel DNA-binding fold in transcriptional regulation. Nat Struct Biol 2001;8:626-633.
30. Surdo PL, Bottomley MJ, Sattler M, Scheffzek K. Crystal structure and nuclear magnetic resonance analyses of the SAND domain from glucocorticoid modulatory element binding protein-1 reveals deoxyribonucleic acid and zinc binding regions. Mol Endocrinol 2003;17:1283-1295.
31. Koh AS, et al. Aire employs a histone-binding module to mediate immunological tolerance, linking chromatin regulation with organ-specific autoimmunity. Proc Natl Acad Sci USA 2008;105:15878-15883.
32. Org T, et al. The autoimmune regulator PHD finger binds to non-methylated histone H3K4 to activate gene expression. EMBO Rep 2008;9:370-376.
33. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-986.
34. Yang S, Bansal K, Lopes J, Benoist C, Mathis D. Aire's plant homeodomain(PHD)-2 is critical for induction of immunological tolerance. Proc Natl Acad Sci USA 2013;110:1833-1838.
35. Heino M, et al. Autoimmune regulator is expressed in the cells regulating immune tolerance in thymus medulla. Biochem Biophys Res Commun 1999;257:821-825.
36. Halonen M, Pelto-Huikko M, Eskelin P, Peltonen L, Ulmanen I, Kolmer M. Subcellular location and expression pattern of autoimmune regulator (Aire), the mouse orthologue for human gene defective in autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED). J Histochem Cytochem 2001;49:197-208.
37. Gardner JM, et al. Deletional tolerance mediated by extrathymic Aire-expressing cells. Science 2008;321:843-847.
38. Yamano T, et al. Thymic B cells are licensed to present self antigens for central T cell tolerance induction. Immunity 2015;42:1048-1061.
39. Nishikawa Y, et al. Biphasic Aire expression in early embryos and in medullary thymic epithelial cells before end-stage terminal differentiation. J Exp Med 2010;207:963-971.
40. Schaller CE, et al. Expression of Aire and the early wave of apoptosis in spermatogenesis. J Immunol 2008;180:1338-1343.
41. Heino M, et al. RNA and protein expression of the murine autoimmune regulator gene (Aire) in normal, RelB-deficient and in NOD mouse. Eur J Immunol 2000;30:1884-1893.
42. Guerau-de-Arellano M, Mathis D, Benoist C. Transcriptional impact of Aire varies with cell type. Proc Natl Acad Sci USA 2008;105:14011-14016.
43. Gray D, Abramson J, Benoist C, Mathis D. Proliferative arrest and rapid turnover of thymic epithelial cells expressing Aire. J Exp Med 2007;204:2521-2528.
44. Villasenor J, Besse W, Benoist C, Mathis D. Ectopic expression of peripheral-tissue antigens in the thymic epithelium: probabilistic, monoallelic, misinitiated. Proc Natl Acad Sci USA 2008;105:15854-15859.
45. Brennecke P, et al. Single-cell transcriptome analysis reveals coordinated ectopic gene-expression patterns in medullary thymic epithelial cells. Nat Immunol 2015;16:933-941.
46. Zhu M, et al. NF-kappaB2 is required for the establishment of central tolerance through an Aire-dependent pathway. J Clin Invest 2006;116:2964-2971.
47. Chin RK, et al. Lymphotoxin pathway directs thymic Aire expression. Nat Immunol 2003;4:1121-1127.
48. Haljasorg U, et al. A highly conserved NF-kappaB-responsive enhancer is critical for thymic expression of Aire in mice. Eur J Immunol 2015;45:3246-3256.
49. LaFlam TN, et al. Identification of a novel cis-regulatory element essential for immune tolerance. J Exp Med 2015;212:1993-2002.
50. Yanagihara T, et al. Intronic regulation of Aire expression by Jmjd6 for self-tolerance induction in the thymus. Nat Commun 2015;6:8820.
51. Org T, et al. AIRE activated tissue specific genes have histone modifications associated with inactive chromatin. Hum Mol Genet 2009;18:4699-4710.
52. Giraud M, et al. Aire unleashes stalled RNA polymerase to induce ectopic gene expression in thymic epithelial cells. Proc Natl Acad Sci USA 2012;109:535-540.
53. Jonkers I, Lis JT. Getting up to speed with transcription elongation by RNA polymerase II. Nat Rev Mol Cell Biol 2015;16:167-177.
54. Oven I, Brdickova N, Kohoutek J, Vaupotic T, Narat M, Peterlin BM. AIRE recruits P-TEFb for transcriptional elongation of target genes in medullary thymic epithelial cells. Mol Cell Biol 2007;27:8815-8823.
55. Giraud M, et al. An RNAi screen for Aire cofactors reveals a role for Hnrnpl in polymerase release and Aire-activated ectopic transcription. Proc Natl Acad Sci USA 2014;111:1491-1496.
56. Yoshida H, et al. Brd4 bridges the transcriptional regulators, Aire and P-TEFb, to promote elongation of peripheral-tissue antigen transcripts in thymic stromal cells. Proc Natl Acad Sci USA 2015;112:E4448-E4457.
57. Jang MK, Mochizuki K, Zhou M, Jeong HS, Brady JN, Ozato K. The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol Cell 2005;19:523-534.
58. Kanno T, et al. BRD4 assists elongation of both coding and enhancer RNAs by interacting with acetylated histones. Nat Struct Mol Biol 2014;21:1047-1057.
59. Nakaoka S, Sasaki K, Ito A, Nakao Y, Yoshida M. A genetically encoded FRET probe to detect intranucleosomal histone H3K9 or H3K14 acetylation using BRD4, a BET family member. ACS Chem Biol 2015. doi:10.1021/cb501046t. [Epub ahead of print].
60. Abramson J, Giraud M, Benoist C, Mathis D. Aire's partners in the molecular control of immunological tolerance. Cell 2010;140:123-135.
61. Liiv I, et al. DNA-PK contributes to the phosphorylation of AIRE: importance in transcriptional activity. Biochim Biophys Acta 2008;1783:74-83.
62. Gaetani M, et al. AIRE-PHD fingers are structural hubs to maintain the integrity of chromatin-associated interactome. Nucleic Acids Res 2012;40:11756-11768.
63. Zumer K, Low AK, Jiang H, Saksela K, Peterlin BM. Unmodified histone H3K4 and DNA-dependent protein kinase recruit autoimmune regulator to target genes. Mol Cell Biol 2012;32:1354-1362.
64. Mathieu AL, et al. PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator-dependent autoimmunity. J Allergy Clin Immunol 2015;135(1578-1588):e1575.
65. Akiyoshi H, et al. Subcellular expression of autoimmune regulator is organized in a spatiotemporal manner. J Biol Chem 2004;279:33984-33991.
66. Pitkanen J, et al. Cooperative activation of transcription by autoimmune regulator AIRE and CBP. Biochem Biophys Res Commun 2005;333:944-953.
67. Chuprin A, et al. The deacetylase Sirt1 is an essential regulator of Aire-mediated induction of central immunological tolerance. Nat Immunol 2015;16:737-745.
68. Sequeira J, et al. sirt1-null mice develop an autoimmune-like condition. Exp Cell Res 2008;314:3069-3074.
69. Kong S, McBurney MW, Fang D. Sirtuin 1 in immune regulation and autoimmunity. Immunol Cell Biol 2012;90:6-13.
70. Biason-Lauber A, et al. Identification of a SIRT1 mutation in a family with type 1 diabetes. Cell Metab 2013;17:448-455.
71. Kuroda N, et al. Development of autoimmunity against transcriptionally unrepressed target antigen in the thymus of Aire-deficient mice. J Immunol 2005;174:1862-1870.
72. Anderson MS, Venanzi ES, Chen Z, Berzins SP, Benoist C, Mathis D. The cellular mechanism of Aire control of T cell tolerance. Immunity 2005;23:227-239.
73. Kekalainen E, et al. A defect of regulatory T cells in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Immunol 2007;178:1208-1215.
74. Laakso SM, et al. Regulatory T cell defect in APECED patients is associated with loss of naive FOXP3(+) precursors and impaired activated population. J Autoimmun 2010;35:351-357.
75. Aricha R, Feferman T, Scott HS, Souroujon MC, Berrih-Aknin S, Fuchs S. The susceptibility of Aire(-/-) mice to experimental myasthenia gravis involves alterations in regulatory T cells. J Autoimmun 2011;36:16-24.
76. Lei Y, et al. Aire-dependent production of XCL1 mediates medullary accumulation of thymic dendritic cells and contributes to regulatory T cell development. J Exp Med 2011;208:383-394.
77. Malchow S, et al. Aire-dependent thymic development of tumor-associated regulatory T cells. Science 2013;339:1219-1224.
78. Perry JS, et al. Distinct contributions of Aire and antigen-presenting-cell subsets to the generation of self-tolerance in the thymus. Immunity 2014;41:414-426.
79. Ahonen P, Myllarniemi S, Sipila I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis- ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 1990;322:1829-1836.
80. Thorpe ES, Handley HE. Chronic tetany and chronic mycelial stomatitis in a child ages 4 and a half years. Am J Dis Child 1929;38:328-338.
81. Neufeld M, Maclaren NK, Blizzard RM. Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine (Baltimore) 1981;60:355-362.
82. Soderbergh A, et al. Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 2004;89:557-562.
83. Orlova EM, et al. Autoimmune polyglandular syndrome type 1 in Russian patients: clinical variants and autoimmune regulator mutations. Horm Res Paed 2010;73:449-457.
84. Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 2002;23:327-364.
85. Alimohammadi M, et al. Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. N Engl J Med 2008;358:1018-1028.
86. Shum AK, et al. BPIFB1 is a lung-specific autoantigen associated with interstitial lung disease. Sci Trans Med 2013;5:206ra139.
87. Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab 2006;91:2843-2850.
88. Bensing S, et al. Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency. Clin Endocrinol (Oxf) 2008;69:697-704.
89. Bjorses P, et al. Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy- candidiasis-ectodermal dystrophy protein. Am J Hum Genet 2000;66:378-392.
90. Stolarski B, et al. Molecular background of polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome in a Polish population: novel AIRE mutations and an estimate of disease prevalence. Clin Genet 2006;70:348-354.
91. Wolff AS, et al. Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. J Clin Endocrinol Metab 2007;92:595-603.
92. Pearce SH, et al. A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1. Am J Hum Genet 1998;63:1675-1684.
93. Millar S, Carson D. Clinical phenotypes of autoimmune polyendocrinopathycandidiasis-ectodermal dystrophy seen in the Northern Ireland paediatric population over the last 30 years. Ulster Med J 2012;81:118-122.
94. Bjorses P, et al. Genetic homogeneity of autoimmune polyglandular disease type I. Am J Hum Genet 1996;59:879-886.
95. Rosatelli MC, et al. A common mutation in Sardinian autoimmune polyendocrinopathy- candidiasis-ectodermal dystrophy patients. Hum Genet 1998;103:428-434.
96. Halonen M, et al. AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype. J Clin Endocrinol Metab 2002;87:2568-2574.
97. Zlotogora J, Shapiro MS. Polyglandular autoimmune syndrome type I among Iranian Jews. J Med Genet 1992;29:824-826.
98. Ramsey C, et al. Aire deficient mice develop multiple features of APECED phenotype and show altered immune response. Hum Mol Genet 2002;11:397-409.
99. Derbinski J, Schulte A, Kyewski B, Klein L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol 2001;2:1032-1039.
100. Jiang W, Anderson MS, Bronson R, Mathis D, Benoist C. Modifier loci condition autoimmunity provoked by Aire deficiency. J Exp Med 2005;202:805-815.
101. Meager A, et al. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med 2006;3:e289.
102. Pontynen N, et al. Aire deficient mice do not develop the same profile of tissue-specific autoantibodies as APECED patients. J Autoimmun 2006;27:96-104.
103. Landegren N, et al. Transglutaminase 4 as a prostate autoantigen in male subfertility. Sci Trans Med 2015;7:292ra101.
104. Strobel P, et al. Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1). J Pathol 2007;211:563-571.
105. Meager A, Vincent A, Newsom-Davis J, Willcox N. Spontaneous neutralising antibodies to interferon-alpha and interleukin-12 in thymoma-associated autoimmune disease. Lancet 1997;350:1596-1597.
106. Zhang J, et al. The type III histone deacetylase Sirt1 is essential for maintenance of T cell tolerance in mice. J Clin Invest 2009;119:3048-3058.
107. + T-regulatory cells. Mucosal Immunol 2014;7:1209-1220.
108. + T-regulatory cell function and prolongs allograft survival. Mol Cell Biol 2011;31:1022-1029.
109. Sobacchi C, Marrella V, Rucci F, Vezzoni P, Villa A. RAG-dependent primary immunodeficiencies. Hum Mutat 2006;27:1174-1184.
110. Khan IS, et al. Enhancement of an anti-tumor immune response by transient blockade of central T cell tolerance. J Exp Med 2014;211:761-768.